OptimizeRx (OPRX) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 8.46% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 78.86% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 154.07% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -12.64% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 38.97% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -30.66% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 40.23% |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn | 56.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.72% |
| Dec 31, 2025 | 146.62% |
| Sep 30, 2025 | 30.27% |
| Jun 30, 2025 | 33.53% |
| Mar 31, 2025 | 17.02% |
| Dec 31, 2024 | -28.91% |
| Sep 30, 2024 | -499.47% |
| Jun 30, 2024 | -135.13% |
| Mar 31, 2024 | -111.79% |
| Dec 31, 2023 | -67.11% |
| Sep 30, 2023 | -104.08% |
| Jun 30, 2023 | -50.79% |
| Mar 31, 2023 | -35.11% |
| Dec 31, 2022 | 47.72% |
| Sep 30, 2022 | -19.98% |
| Jun 30, 2022 | -108.01% |
| Mar 31, 2022 | -650.45% |
| Dec 31, 2021 | 71.00% |
| Sep 30, 2021 | -51.07% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -25.99% |
| Dec 31, 2020 | 86.63% |
| Sep 30, 2020 | 30.66% |
| Jun 30, 2020 | -20.51% |
| Sep 30, 2018 | 76.92% |
| Dec 31, 2017 | -59.79% |
| Jun 30, 2017 | -66.99% |
| Sep 30, 2015 | 33.16% |
| Dec 31, 2014 | 27.20% |
| Jun 30, 2014 | 25.04% |
| Mar 31, 2014 | -75.74% |
| Dec 31, 2013 | 40.67% |
| Sep 30, 2013 | 36.48% |